Skip to main content
. 2022 Jan 13;2022:4524032. doi: 10.1155/2022/4524032

Table 2.

Associations between PhenoAge, PhenoAgeAccel, and all-cause mortality on follow-up.

Variable HR (95% CI)
Model 1a Model 2b Model 3c
PhenoAge (per year) 1.05 (1.02, 1.08)∗∗∗ 1.06 (1.03, 1.09)∗∗∗ 1.04 (1.01, 1.08)
PhenoAge (per 10 years) 1.63 (1.27, 2.11)∗∗∗ 1.74 (1.34, 2.27)∗∗∗ 1.51 (1.10, 2.08)
PhenoAgeAccel subgroups
 Negative Reference Reference Reference
 Positive 2.29 (1.38, 3.81)∗∗ 2.58 (1.51, 4.41)∗∗ 2.08 (1.14, 3.80)

Results are based on COX regression analysis. HR: hazard ratio; PhenoAge: phenotypic age; PhenoAgeAccel: phenotypic age acceleration. aModel 1 adjusted for chronological age. bModel 2 additionally adjusted for lesion number, disease count, and revascularization. cModel 3 additionally adjusted for other traditional cardiovascular risk factors, including gender, smoking, drinking, body mass index, serum uric acid, creatine kinase, creatine phosphokinase isoenzyme, total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and N-terminal probrain natriuretic peptide. +P < 0.1; P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001.